These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1080851)

  • 21. Treating psoriasis as a T-cell mediated disease.
    Leonardi C
    Manag Care; 2004 Apr; 13(4 Suppl Treating Psoriasis):1, 3-8. PubMed ID: 15282980
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lymphocytes and their subpopulations in psoriasis].
    Vignale R; Pereira A; Paciel J; Galbarini E
    Med Cutan Ibero Lat Am; 1984; 12(3):193-8. PubMed ID: 6384688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T lymphocyte subpopulations in alopecia areata and psoriasis: identification with monoclonal antibodies and Fc receptors.
    Gu SQ; Petrini B; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1983; 63(3):244-6. PubMed ID: 6192643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subpopulations of immunocompetent cells in patients with liver cirrhosis studied using monoclonal antibodies].
    Podymova SD; Rachvelishvili NB; Tabagari DZ
    Ter Arkh; 1988; 60(11):49-53. PubMed ID: 3266373
    [No Abstract]   [Full Text] [Related]  

  • 25. [Imbalance of T lymphocyte subpopulations in patients with psoriasis and its immune correction].
    Rubins AJ; Mashkilleysson AL; Merson AG; Gipsh NM
    Z Hautkr; 1987 Mar; 62(6):497-501. PubMed ID: 2954313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro system for determining the use of immunocorrective agents in patients with disseminated psoriasis].
    Vasil'eva LL; Amirova IA
    Vestn Dermatol Venerol; 1984 Oct; (10):6-8. PubMed ID: 6334943
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunologic changes and treatment with cyclosporin A in a case of erythrodermic psoriasis].
    Galasso F; Sbano E; Altamura V
    G Ital Dermatol Venereol; 1988 Apr; 123(4):193-6. PubMed ID: 2972608
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cytotoxicity in psoriasis].
    Vignale RA; Lasalvia E; Borras A
    Med Cutan Ibero Lat Am; 1984; 12(1):25-8. PubMed ID: 6376977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Increase of circulating HLA DR+ T lymphocytes in psoriasis].
    Paciel J; Vignale RA; Bruno J; Vázquez G; De Anda G
    Med Cutan Ibero Lat Am; 1984; 12(6):497-500. PubMed ID: 6397671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Letter: Presence of serum anti-gamma globulin factors in psoriasis].
    Guilhou JJ; Meynadier J; Clot J
    Nouv Presse Med; 1973 Nov; 2(41):2750. PubMed ID: 4589879
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
    Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired B lymphocyte function in immune disorders. An overview and presentation of five patients with hypogammaglobulinaemia.
    Tauris P; Madsen M; Andersen P
    Dan Med Bull; 1984 Dec; 31(6):475-82. PubMed ID: 6394222
    [No Abstract]   [Full Text] [Related]  

  • 33. [Subpopulations of peripheral T lymphocytes (Th/Ts) in atopic dermatitis and in psoriasis].
    Klene U; Gollnick H; Bauer R; Orfanos CE
    Hautarzt; 1986 Jan; 37(1):17-22. PubMed ID: 2936698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psoriasis treatment by hemosorption using a synthetic charcoal hemosorbent].
    Glukhen'kiĭ BT; Krishtof AN; Amalian VA; Karpenko VV; Nemchikov MIu
    Vestn Dermatol Venerol; 1982; (12):10-3. PubMed ID: 6984260
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppressor cell defect in psoriasis.
    Sauder DN; Bailin PL; Krakauer S
    Adv Exp Med Biol; 1979; 121B():299-305. PubMed ID: 161851
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinico-immunological correlations in psoriatic arthritis based on data from determining cellular (T- and B-lymphocytes) and humoral (IgG, IgA and IgM) immunity factors].
    Nikulin NK; Starostina ZD; Komarova VD
    Vestn Dermatol Venerol; 1981 Sep; (9):10-4. PubMed ID: 6975543
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quantitative T- and B-lymphocyte correlations in patients with T. rubrum infection, pyodermatitis, syphilis and psoriasis].
    Fedotov VP; Lesnitskiĭ AI; Manuĭlova LA; Zheliaz EV
    Vestn Dermatol Venerol; 1982 Mar; (3):16-21. PubMed ID: 6978579
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological reactivity of patients with simple psoriasis. II. T-lymphocyte markers in TE rosette tests].
    Turowski G; Kapińska-Mrówka M
    Przegl Dermatol; 1980; 67(6):723-8. PubMed ID: 6972551
    [No Abstract]   [Full Text] [Related]  

  • 39. T and B lymphocyte rosettes in bronchial asthma.
    Ghazanshahi S; Townley R; Chaperone E; Villacorte G
    Ann Allergy; 1976 May; 36(5):324-9. PubMed ID: 1084715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modulation of the lymphocyte membrane with anti-HLA ABC in psoriasis].
    Paciel J; Vignale RA; Pereira A
    Med Cutan Ibero Lat Am; 1984; 12(5):403-8. PubMed ID: 6396466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.